Sangamo Therapeutics, Inc.
US ˙ OTCPK ˙ US8006771062

SecuritySGMO / Sangamo Therapeutics, Inc.
InstitutionCerity Partners LLC
Latest Disclosed Ownership163,943 shares
Latest Disclosed Value $ 40,478
Cerity Partners LLC ownership in SGMO / Sangamo Therapeutics, Inc.

On May 15, 2026 - Cerity Partners LLC filed a 13F-HR form disclosing ownership of 163,943 shares of Sangamo Therapeutics, Inc. (US:SGMO) valued at $40,478 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 163,943 shares of Sangamo Therapeutics, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $29,116 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F SANGAMO THERAPEUTICS COM 800677106 163,943 0 0.00 40 -41.18 0.0000
2026-02-11 2025-12-31 13F SANGAMO THERAPEUTICS COM 800677106 163,943 -15,725 -8.75 69 -43.33 0.0001
2025-10-22 2025-09-30 13F SANGAMO THERAPEUTICS Stock 800677106 179,668 129,668 259.34 121 344.44 0.0002
2025-08-13 2025-06-30 13F SANGAMO THERAPEUTICS Stock 800677106 50,000 -5,000 -9.09 27 -25.00 0.0000
2025-04-30 2025-03-31 13F SANGAMO THERAPEUTICS Stock 800677106 55,000 44,800 439.22 36 260.00 0.0001
2025-02-13 2024-12-31 13F SANGAMO THERAPEUTICS Stock 800677106 10,200 200 2.00 10 25.00 0.0000
2024-11-12 2024-09-30 13F SANGAMO THERAPEUTICS Stock 800677106 10,000 0 0.00 9 166.67 0.0000
2024-08-13 2024-06-30 13F SANGAMO THERAPEUTICS Stock 800677106 10,000 0 0.00 4 -50.00 0.0000
2024-05-14 2024-03-31 13F SANGAMO THERAPEUTICS Stock 800677106 10,000 0 0.00 7 20.00 0.0000
2024-01-26 2023-12-31 13F SANGAMO THERAPEUTICS Stock 800677106 10,000 10,000 5 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.